Research location
Medford
New Jersey, United States
Advertisement
Research activity in Medford
New Jersey, United StatesCureCurrent currently publishes aggregate city-level research activity for this location: 8 trials and 8 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Medford
8 linked trials · page 1 of 1A Study of the Safety of Rituxan in Patients With Rheumatoid Arthritis After an Inadequate Response to Previous Anti-TNF Therapy (SUNSTONE)NCT00443443 · 2007-01-01 · 1 site observation
COMPLETED
Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or NaproxenNCT00346216 · 2006-10-04 · 1 site observation
COMPLETED
A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate TherapyNCT00106522 · 2005-05-01 · 1 site observation
COMPLETED
A Study to Assess the Effect of Tocilizumab + Methotrexate on Prevention of Structural Joint Damage in Patients With Moderate to Severe Active Rheumatoid Arthritis (RA)NCT00106535 · 2005-01-01 · 1 site observation
COMPLETED
Study of Eszopiclone Compared to Placebo on Daytime Function in Subjects With Insomnia Related to Rheumatoid ArthritisNCT00367965 · 2004-02-01 · 1 site observation
COMPLETED
Treatment for Symptomatic Peripheral Neuropathy in Patients With DiabetesNCT00044395 · 2002-07-01 · 1 site observation
COMPLETED
Treatment of Peripheral Neuropathy in Patients With DiabetesNCT00044421 · 2002-07-01 · 1 site observation
COMPLETED
A Multi-Center Trial to Compare Three Doses of Meloxicam and Placebo in Patients With Rheumatoid ArthritisNCT00042068 · 2002-06-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.